<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-PAK-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Pakistan (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Pakistan: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Acasus</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">IRD Global Limited</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.21107.35" role="4">
   <narrative xml:lang="EN">Johns Hopkins University</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Precision Health Consultants Global</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Pakistan</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="PK" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="PK" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Islamabad</narrative>
   </name>
   <administrative code="PK" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>33.72148 73.04329</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">4553309</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">5016261</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">4485465</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1449628</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="PAKPEF-TCA-ACASUS2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">726795</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">246400</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-CHIP2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">199028</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-IBRD2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">120000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-IRD2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">478921</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">493280</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">1136933</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">1151952</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-ACASUS2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">597134</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">134400</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-CHIP2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">100001</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-IBRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-IRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">65476</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-JHU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">95285</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">162137</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-PATH2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-69306</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-PATH (PATH)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PATH</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">30000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1620560</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">2080574</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-ACASUS2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">505789</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">44800</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-CHIP2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">22564</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-IBRD2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-IRD2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">501068</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-JHU2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">250935</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">74772</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-PHC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">103251</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-PHC (Precision Health Consultants Global)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Precision Health Consultants Global</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">60226</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1337178</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1384882</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-ACASUS2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">141750</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-IRD2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">245250</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-JHU2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">332447</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-PHC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">49609</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-PHC (Precision Health Consultants Global)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Precision Health Consultants Global</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">334295</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PAKPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">346279</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000990">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">229100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001152">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">247100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006967">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">315523</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000989">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">199100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000988">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">53072</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001260">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-317100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-53072</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">53072</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000316">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-12"></transaction-date>
   <value currency="USD" value-date="2020-02-12">66476</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000502">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-21"></transaction-date>
   <value currency="USD" value-date="2020-02-21">58495</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000743">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-09"></transaction-date>
   <value currency="USD" value-date="2020-03-09">-58495</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000984">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-30"></transaction-date>
   <value currency="USD" value-date="2020-03-30">-58495</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001267">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="USD" value-date="2020-03-31">199100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-22"></transaction-date>
   <value currency="USD" value-date="2020-04-22">51920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001227">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-23"></transaction-date>
   <value currency="USD" value-date="2020-04-23">199100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-14213</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-1513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-64812</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">14213</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">1513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">64812</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004428">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-14"></transaction-date>
   <value currency="USD" value-date="2021-09-14">98040</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005676">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-29"></transaction-date>
   <value currency="USD" value-date="2021-10-29">122550</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">9867</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000575">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-31"></transaction-date>
   <value currency="USD" value-date="2022-01-31">147060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000827">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">184800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000675">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-02"></transaction-date>
   <value currency="USD" value-date="2019-12-02">61600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">134400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001204">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">44800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006946">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-17337</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006951">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-33279</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006952">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-85772</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">17337</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006950">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">19929</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006954">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">33279</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006948">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">35381</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006953">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">47174</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006955">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">85772</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006947">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">8893</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006968">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">55870</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">31780</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-31780</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001837">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-06"></transaction-date>
   <value currency="USD" value-date="2020-05-06">43246</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003801">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-17"></transaction-date>
   <value currency="USD" value-date="2020-09-17">22467</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005207">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">10812</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005206">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">23378</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-22564</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">22564</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHIP (Civil Society Human and Institution)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Civil Society Human and Institution</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000987">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">119051</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001149">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">9664</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001291">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-17337</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006939">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-17337</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006940">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-19929</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006944">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-33279</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006938">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-35381</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006943">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-47174</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006945">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-85772</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006937">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">-8893</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006936">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">17337</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006941">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">33279</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006942">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-01"></transaction-date>
   <value currency="USD" value-date="2019-09-01">85772</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CSHIDP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001121">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">120000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002781">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-17"></transaction-date>
   <value currency="USD" value-date="2021-06-17">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000988">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">150836</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001150">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">120030</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001292">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-208055</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006969">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">217940</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000983">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">62811</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">135360</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-135360</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000347">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-17"></transaction-date>
   <value currency="USD" value-date="2020-02-17">56845</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000346">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-17"></transaction-date>
   <value currency="USD" value-date="2020-02-17">78514</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000059">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-01"></transaction-date>
   <value currency="USD" value-date="2021-03-01">9056</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000792">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-02"></transaction-date>
   <value currency="USD" value-date="2021-03-02">36224</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000058">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-08"></transaction-date>
   <value currency="USD" value-date="2021-04-08">20196</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001582">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-08"></transaction-date>
   <value currency="USD" value-date="2021-04-08">36224</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004416">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-14"></transaction-date>
   <value currency="USD" value-date="2021-09-14">163500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004990">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-25"></transaction-date>
   <value currency="USD" value-date="2021-10-25">36224</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004910">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-25"></transaction-date>
   <value currency="USD" value-date="2021-10-25">9056</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005920">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-09"></transaction-date>
   <value currency="USD" value-date="2021-11-09">9056</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004911">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-29"></transaction-date>
   <value currency="USD" value-date="2021-11-29">9056</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">136250</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IRD (IRD Global Limited)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">IRD Global Limited</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000981">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">75348</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001141">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-37674</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001285">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-37674</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000002">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-08"></transaction-date>
   <value currency="USD" value-date="2021-02-08">5445</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000043">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-11"></transaction-date>
   <value currency="USD" value-date="2021-02-11">4844</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">-12852</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">12852</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001891">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">1567</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003020">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">44586</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003021">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">69</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">-1567</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">-69</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">-7353</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">1567</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">69</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-31"></transaction-date>
   <value currency="USD" value-date="2021-07-31">7353</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004256">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">307</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004299">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">37</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">5211</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005410">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">6196</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004969">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">74</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005445">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">8236</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006742">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-1567</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-5410</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006742">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-69</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006742">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-7353</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006742">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">1567</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">5410</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006742">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">69</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006742">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">7353</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JHU (Johns Hopkins University)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.21107.35">
    <narrative xml:lang="EN">Johns Hopkins University</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000989">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">246932</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001151">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">89743</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001293">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-187589</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003822">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">72470</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006970">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">40535</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000981">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-17"></transaction-date>
   <value currency="USD" value-date="2019-12-17">26766</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">204421</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-204421</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000901">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-07"></transaction-date>
   <value currency="USD" value-date="2020-04-07">44711</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001452">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-08"></transaction-date>
   <value currency="USD" value-date="2020-04-08">48603</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001083">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-08"></transaction-date>
   <value currency="USD" value-date="2020-04-08">53832</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002894">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-13"></transaction-date>
   <value currency="USD" value-date="2020-07-13">76500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003889">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-05"></transaction-date>
   <value currency="USD" value-date="2020-10-05">62304</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005370">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">60717</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001911">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">50559</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">26536</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-PHC (Precision Health Consultants Global)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Precision Health Consultants Global</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-226</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">226</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">27400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000828">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">1003176</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">133757</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">200635</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">1002884</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-133757</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">133757</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">283284</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">334295</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">750870</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000829">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">1047229</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">104723</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">1038138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001655">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">244353</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-104723</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">104723</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">693360</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-27"></transaction-date>
   <value currency="USD" value-date="2021-04-27">346046</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">1038836</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-pakistan-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Pakistan 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-pakistan-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Pakistan 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-pakistan-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Pakistan 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-pakistan-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Pakistan 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-pakistan-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Pakistan 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-pakistan-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Pakistan 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-pakistan-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Pakistan 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-pakistan-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Pakistan 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-PAK" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Developed plans and framework for year 3 Operational Deployment Plan (ODP) for Cold Chain Equipment ( CCE)

(2) Completed EVM assessment report and Costed Improvement Plan (cIP).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Develop an immunization supply chain, Management Information System for vaccine and cold chain, conduct cold chain assessments and bottleneck analysis, develop training module, contribute to cold chain assessment for new vaccine introduction and mass immunization campaign. Contribute EVM and improvement plans, develop EPI supply chain road map

The staff member is also the focal point for COVID 19 vaccine roll out and monitoring appropriate planning and implementation, through monitoring cold chain and C4D specialists at subnational level

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">A cold chain assessment was conducted in 2014 which was used as a baseline for cold chain infrastructure development and guided the cold chain optimization platform (CCEOP) application to GAVI in 2016. UNICEF supported the procurement and deployment of 15418 equipment through a three year CCEOP support received from GAVI (11,604 installed in the first two years of CCEOP, 3550 installed in year three of CCEOP).
Temperature monitoring devices (RTMDs) are installed in all ILRs to be integrated with the vLMIS for real-time reporting, 600 of the RTMDs will be piloted in health facilities of six districts of Punjab and Sindh, and the lesson learned will guide the scaled up to other locations 11,000 CCE across the country. 
UNICEF provided support in the construction of 16 warehouses for expanded programme on immunization (EPI), Installation of 33 cold rooms and centralized TMDs in 37 cold rooms as well as generators in 12 warehouses across Pakistan,
An effective vaccine management assessment (EVMA) have been completed identifying challenges to be addressed at all levels and accordingly, a system design is underway, aimed at making the distribution network more efficient.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Integrated 600 CCE with RTMDs.

(2) Documented cold chain equioment optamization plan (CCEOP) implementation and progress on establishment of CCE maintenance infrastructure</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Develop an immunization supply chain, Management Information System for vaccine and cold chain, conduct cold chain assessments and bottleneck analysis, develop training module, contribute to cold chain assessment for new vaccine introduction and mass immunization campaign. Contribute EVM and improvement plans, develop EPI supply chain road map

The staff member is also the focal point for COVID 19 vaccine roll out and monitoring appropriate planning and implementation, through monitoring cold chain and C4D specialists at subnational level

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Duplication: Milestone progress already reported above. This milestone needs to be removed as its a duplication.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&quot;1. Provinces are efficiently guided and coordinated for urban immunization action plans, and implementation.
2. Documented progress of the implementation of action plans in targetted districts and mega cities.
3. Support provided to the development of Gavi full portfolio/HSS-III planning.&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for HSS through immunization system strengthening, and PHC for UHC ; determine the focus, strategies and monitor the implementation, to increase vaccine uptake in urban poor populations with the highest level of inequities.">
      <location ref="PK"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">As part of the urban action plan, 6 urban consultant were recruited (1 in each province) to the support the implementation of urban specific immunity boosting activities (birth dose, intensified monitoring, supporting campaigns in the megacities,). An urban action plan was developed, with an equity lens in Punjab and Balochistan, while Sindh action plan is pending secretary health approval, and remains KP. The pandemic slowed down the implementation, although most of the strategies included in the EPI recovery plan (intra COVID pandemic) and EPI/PEI synergy activities and ISD are also targeting the 41 SHRUCS in addition to the HSS2 districts (detection of zero dose and defaulters thanks to the integrate referral slip, 24/7 birth dose initiative in Quetta, Peshawar and and Karachi megacities. 
The training of 3000 vaccinators was interrupted for the MR campaign after 103 trainers were trained and will roll out the activity immediately after the campaign. 30 vehicles have been procured to support mobile vaccination teams /ISD teams in urban poor settings, and are being used for announcement in megacities. 
Governance strengthening to insure supportive supervision, accountability on the results, and increased investment EPI HR and structures remains the challenge.
The highest COVID 19 positivity rates were observed in the megacities and provided an opportunity to identify high risk population for EPI.
Minor delays due to the COVID pandemic lockdowns and MR campaign among other competing priorities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documented knowledge products,Case studies, lesson learned, best practices and human interest stories.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for HSS through immunization system strengthening, and PHC for UHC ; determine the focus, strategies and monitor the implementation, to increase vaccine uptake in urban poor populations with the highest level of inequities.">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Duplication: Milestone progress already reported above. This milestone needs to be removed as its a duplication.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documented progress on equitable delivery of immunization services at all levels (Provincial,District,Facility and Community level).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Advocacy, planning and implementation of agreed strategies (Equity led implementation in urban poor and remote rural, ISD (DCP3 package) in SHRUCs). Monitor and measure program implementation, rational use of funding, timely reporting.
The staff member is also the focal point for COVID 19 vaccine roll out and monitoring appropriate planning and implementation, through monitoring cold chain and C4D specialists at subnational level

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Duplication: Milestone progress already reported above. This milestone needs to be removed as its a duplication.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Timely planning and implementation of Immunization strategies to reach missed children,
Documented progress on implementation of EPI action plans to reach children with vaccines in targetted districts.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Advocacy, planning and implementation of agreed strategies (Equity led implementation in urban poor and remote rural, ISD (DCP3 package) in SHRUCs). Monitor and measure program implementation, rational use of funding, timely reporting.
The staff member is also the focal point for COVID 19 vaccine roll out and monitoring appropriate planning and implementation, through monitoring cold chain and C4D specialists at subnational level

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Same strategies as in Balochistan: after COVID 19 pandemic, mitigation strategies&apos; implemented to limit impact on the regular program (part of EPI recovery plan,) UNICEF has launched the birth dose initiative in 12 sites of Quetta megacity (only 1 site up to February 2020). As a result the coverage for BCG, OPV0 and Hepatitis B at birth rose to 97% (19% previously), thanks to a gender and equity sensitive approach (vaccination desk in the labor rooms, vaccine administered by female vaccinators available 27/7 to give the same opportunity for the birth dose to all babies, regardless of the time of birth), leveraging public private partnership (sites in both public and private facilities). Progress is being made through the digitization of the data system, to follow up each baby after the birth dose, until completion of the schedule.
As part of the EPI/PEI synergy opportunities for strengthening the immunity in low coverage areas of which Quetta, through:
- joint Planning and supportive supervision of RI, coverage by EPI of zero dose children identified during polio campaigns and AFP surveillance, as well as subsequent follow up for coverage in 672, 568 children in 2021. Quetta benefited as a priority polio district. 
- An integrated referral slip was developed (EPI, nutrition, ANC/PNC), to detect eligible children during house to house activities conducted by FLW, to link them to the health facility. 
- Co administration of OPV in EPI campaigns (TCV, MR), 
- Evening and weekend shifts are planned in the slums (population unavailable in regular opening hours of the health facility)
- Health camps organized, offering EPI, nutrition, Wash, curative care, ANC and PNC services, in polio tier 1 districts to reduce the resistance to polio due to many campaigns at close interval. Impact on zero dose and defaulters for routine immunization, was confirmed by the third party vaccination coverage survey (Q1 2021), showing 37.5% FIC compared 28.8% per PDHS 2018.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Development of Communications and Surveillance materials, including crisis and risk communication plans. Development of Vaccine Related Event response plan. Training of Federal and Provincial level staff on the VRE plan.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Adequate and timely response to vaccine related events (VREs) is critical to restoring public trust in vaccines and mitigating long-term impact on the immunization system. Pakistan is particularly vulnerable to VREs due to its weak routine immunization infrastructure. We aim to support Pakistan in the development of a high quality vaccine related event plan, consisting of 4 phases. 1 ? Assessment of AEFI system 2 ? Assessment of communication and surveillance around vaccine related events 3 ? Development of communications and surveillance materials. Identify where more work is needed to be done 4 ? Develop a Vaccine Related Event Response Plan 5 - Training of Federal and Provincial level staff on the VRE plan.">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">CDC has helped develop a Federal level VRE response plan for the country. Because of COVID-19 delays and restrictions, we did not have the opportunity to develop provincial level plans, nor train on the plans.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report on TCV planning, implementation and lessons learned from Gavi TCV implementation. Final reports of technical assistance for monitoring and evaluation activities.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for Gavi supported TCV introduction approved for Pakistan. Work in collaboration with the MOH and other keep partners for planning and evaluation of the first phase of the introduction in 2019. TCV introduction in Pakistan is especially important to document given the occurence of the extensively drug resistant typhoid outbreak.">
      <location ref="PK"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Previously, CDC had been in close touch with AKU and Gavi on the impact evaluation in Pakistan. CDC participated in AKU technical discussion calls on study design and provided feedback. CDC (HQ and country office) have had follow-up discussions with AKU and MOH on NIH-FETP involvement but these discussions have not gone any further. We are looking to reprogram the funds. One potential activity is to improve typhoid surveillance reporting in the weekly SitRep by the MOH. This information from the provinces with typhoid surveillance where FETP are active would help monitor TCV impact.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Initial report on technical assistance for planning and implementation of the campaign.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the first Gavi-supported Typhoid Gavi supported TCV introduction in Pakistan (approved Gavi application). Work in collaboration with the MOH, WHO and other partners (Aga Khan University) for planning and evaluation of the introduction in 2019 and 2020. CDC will be a key technical partner for AKU for evaluation of the TCV campaign over 3 - 4 years (CDC-HQ activities planned through TCA funds and will responsible for close coordination between the CDC in-country staff and other partners). TCV introduction in Pakistan is especially important to document given the occurence of the extensively drug resistant typhoid outbreak and impact of TCV on XRD outbreak control will be critical.">
      <location ref="PK"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Previously, CDC had been in close touch with AKU and Gavi on the impact evaluation in Pakistan. CDC participated in AKU technical discussion calls on study design and provided feedback. CDC (HQ and country office) have had follow-up discussions with AKU and MOH on NIH-FETP involvement but these discussions have not gone any further. We are looking to reprogram the funds. One potential activity is to improve typhoid surveillance reporting in the weekly SitRep by the MOH. This information from the provinces with typhoid surveillance where FETP are active would help monitor TCV impact.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Lahore: Action Plans are rolled out in the targeted districts and progress assessed on a monthly basis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="NOB - Immunisation officer, Lahore: Provide technical assistance to provincial, district, area and facility level in equity focused planning/ microplanning, implementation of plans and monitoring of DLIs at all levels in respective provinces">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Duplication: Milestone progress already reported above. This milestone needs to be removed as its a duplication. please refer to approved/agreed milestones for June 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documented progress on implementation of costed action plans to reach children with vaccines in targetted districts.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Advocacy, synergistic approaches with other sectors and within health Support immunization program focus on missed children of Balochistan (urban poor in megacities, remote rural populations), as well as ISD/ synergy activities (implementation of DCP3 pakage in 18 SHRUCS). Provide Technical assistance for hard to reach areas due to insecurity and terrain by using experience in other countries that has helped reduce inequalities for marginalized population. More specifically work with the Government, WHO, local communities and organization in planning and delivery of services tailored to specific areas. By combining intergration with Nutrition and other services, provide services that will improve the uptake of RI and reduce zero dose as well as bring health services to communities. Support the establishment of mobile health to hard to reach areas and make sure that remote and hard to reach communities are reached with services.
The staff member is also the focal point for COVID 19 vaccine roll out and monitoring appropriate planning and implementation, through monitoring the EPI specialist, the urban consultant, the ISD consultant, cold chain and C4D specialists at subnational level

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Duplication: Milestone progress already reported above. This milestone needs to be removed as its a duplication.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Timely planning and implementation of Immunization strategies to reach missed children, in Balochistan.
Documented progress on implementation of EPI action plans to reach children with vaccines in targetted districts.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Advocacy, synergistic approaches with other sectors and within health Support immunization program focus on missed children of Balochistan (urban poor in megacities, remote rural populations), as well as ISD/ synergy activities (implementation of DCP3 pakage in 18 SHRUCS). Provide Technical assistance for hard to reach areas due to insecurity and terrain by using experience in other countries that has helped reduce inequalities for marginalized population. More specifically work with the Government, WHO, local communities and organization in planning and delivery of services tailored to specific areas. By combining intergration with Nutrition and other services, provide services that will improve the uptake of RI and reduce zero dose as well as bring health services to communities. Support the establishment of mobile health to hard to reach areas and make sure that remote and hard to reach communities are reached with services.
The staff member is also the focal point for COVID 19 vaccine roll out and monitoring appropriate planning and implementation, through monitoring the EPI specialist, the urban consultant, the ISD consultant, cold chain and C4D specialists at subnational level

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Following the COVID 19 pandemic, to mitigate its impact on the regular program, as part of the EPI recovery plan, UNICEF has launched the birth dose initiative in 12 sites of Quetta district (only 1 site up to February 2020), a megacity with high proportion of urban poor populations. As a result the coverage for BCG, OPV0 and Hepatitis B at birth rose to 97% (19% previously), thanks to a gender and equity sensitive approach (vaccination desk in the labor rooms, vaccine administered by female vaccinators available 27/7 to give the same opportunity for the birth dose to all babies, regardless of the time of birth), leveraging public private partnership (sites in both public and private facilities). Progress is being made through the digitization of the data system, to follow up each baby after the birth dose, until completion of the schedule.
As part of the EPI/PEI synergy opportunities for strengthening the immunity in low coverage areas of which Quetta, through:
- joint Planning and supportive supervision of RI, coverage by EPI of zero dose children identified during polio campaigns and AFP surveillance, as well as subsequent follow up for coverage in 672, 568 children in 2021. Quetta benefited as a priority polio district. 
- An integrated referral slip was developed (EPI, nutrition, ANC/PNC), to detect eligible children during house to house activities conducted by FLW, to link them to the health facility. 
- Co administration of OPV in EPI campaigns (TCV, MR), 
- Evening and weekend shifts are planned in the slums (population unavailable in regular opening hours of the health facility)
- Health camps organized, offering EPI, nutrition, Wash, curative care, ANC and PNC services, in polio tier 1 districts to reduce the resistance to polio due to many campaigns at close interval. Impact on zero dose and defaulters for routine immunization, was confirmed by the third party vaccination coverage survey (Q1 2021), showing 37.5% FIC compared 28.8% per PDHS 2018.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Progress reports are available to inform immuization programming</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Monitor program implementation results to guide further programming: regular data collection and analysis, including with CSOs to report for UNICEF.
Knowledge management

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as

they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Duplication: Milestone progress already reported above. This milestone needs to be removed as its a duplication.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Monitor program implementation results to guide further programming: regular data collection and analysis, including with CSOs to report for UNICEF.
Knowledge management

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as

they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF has submitted all donors progress reports on time: 
1.	NISP MDTF progress report
2.	HSS 2 Additional funding ? Progress report
3.	Performance Based Funding (PBF) Grant Progress Report</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Bottlenecks to primary health services-related budget/funds flow to sub-national/specific geographic areas identified.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Gavi funds over the past few years were used to provide technical assistance to the federal and provincial governments of Pakistan to enhance capacity for health accounting (through the immunization accounts which includes off-budget) and expenditure tracking to ensure that immunization funds are managed in a transparent and accountable manner. With TCA 2021, the World Bank will focus on i) improving budget autonomy and expenditure efficiency at the primary health centers for integrated health services, ii) strengthening internal control at the primary health centers, including asset management and iii) Dissemination of WB?s report &quot;Towards sustainable financing of routine immunization in Pakistan: A Financial Analysis&quot;, funded with NISP BETF/Gavi TCA funds. Budget execution issues highlighted in the report, especially between federal and provincial levels will also be explored further to provide practical recommendations taken forward through TA to the Government within country engagement.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Gavi TCA leveraged a larger program of work in Pakistan, including: 
1.	Review of National Immunization accounts. Based on years of capacity building, the EPI team for the first time has prepared national immunization accounts on its own. The consultant who have been working with them in past provided quality assurance this year. The EPI team will present immunization accounts during upcoming joint appraisal mission.
2.	Guidelines for Chief Finance and Account Officer (CFAO) in Ministry of Health. The federal PFM law of 2019 now requires that each ministry should be assigned a CFAO, who will assist the Secretary with budget preparation and will be a liaison between finance and ministry. A CFAO has been assigned in Ministry of Health. With TCA funds, we developed guidelines to assist CFAO in discharge of his responsibilities. These guidelines are discussed with the CFAO and MoF. The guidelines will strengthen internal control of the ministry of Health.
3.	Internal Audit guidelines for Health ? We are in discussion with MoF for institutionalizing internal audit in MoH. It also suggests institutional structure for internal audit.
4.	Policy note on Strong Public Financial Management System to attain Universal Health Coverage in a decentralized service delivery system?: A draft policy paper drawing lessons from PFM reforms in NISP to guide implementation of essential health service package at districts and primary health care.
5.	Internal control assessment at primary health care centers. The assessment includes deep dive in the Basic health unit expenditure and suggest ways to improve expenditure efficiency.
6.	Budget expenditure analysis the assessment includes provincial analysis over a period of 3 years of both UHC and its associated budgets and secondly district wise results, with template to ensure sub national monitoring
7.	Assessment of National Health Accounts: Assessment and comparison with system of health accounts was carried out</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Dissemination of WB?s report &quot;Towards sustainable financing of routine immunization in Pakistan: A Financial Analysis&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Gavi funds over the past few years were used to provide technical assistance to the federal and provincial governments of Pakistan to enhance capacity for health accounting (through the immunization accounts which includes off-budget) and expenditure tracking to ensure that immunization funds are managed in a transparent and accountable manner. With TCA 2021, the World Bank will focus on i) improving budget autonomy and expenditure efficiency at the primary health centers for integrated health services, ii) strengthening internal control at the primary health centers, including asset management and iii) Dissemination of WB?s report &quot;Towards sustainable financing of routine immunization in Pakistan: A Financial Analysis&quot;, funded with NISP BETF/Gavi TCA funds. Budget execution issues highlighted in the report, especially between federal and provincial levels will also be explored further to provide practical recommendations taken forward through TA to the Government within country engagement.">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The Financial sustainability report is disseminated to the government and the partners. A webinar was organized on April 19 to present and discuss results of this work with the EPI Director, BMGF, Gavi and partners.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap to improve financial sustainability discussed with government</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Gavi funds over the past few years were used to provide technical assistance to the federal and provincial governments of Pakistan to enhance capacity for health accounting (through the immunization accounts which includes off-budget) and expenditure tracking to ensure that immunization funds are managed in a transparent and accountable manner. With TCA 2020, the World Bank will focus on the financial sustainability of immunization financing with GAVI transitioning and strenthening controls and accountability to ensure that funds are used for purpose intended. This work will build upon findings of the WB?s work on analytics assessing the control assessment and financial sustainability and efficiency of immunization financing expected to be completed by March 2020.">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The roadmap for financial sustainability is developed and agreed with the counterparts.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Gavi funds over the past few years were used to provide technical assistance to the federal and provincial governments of Pakistan to enhance capacity for health accounting (through the immunization accounts which includes off-budget) and expenditure tracking to ensure that immunization funds are managed in a transparent and accountable manner. With TCA 2020, the World Bank will focus on the financial sustainability of immunization financing with GAVI transitioning and strenthening controls and accountability to ensure that funds are used for purpose intended. This work will build upon findings of the WB?s work on analytics assessing the control assessment and financial sustainability and efficiency of immunization financing expected to be completed by March 2020.">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The roadmap for financial sustainability is developed and agreed with the counterparts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Methodology to implement actions identified in the roadmap.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Gavi funds over the past few years were used to provide technical assistance to the federal and provincial governments of Pakistan to enhance capacity for health accounting (through the immunization accounts which includes off-budget) and expenditure tracking to ensure that immunization funds are managed in a transparent and accountable manner. With TCA 2020, the World Bank will focus on the financial sustainability of immunization financing with GAVI transitioning and strenthening controls and accountability to ensure that funds are used for purpose intended. This work will build upon findings of the WB?s work on analytics assessing the control assessment and financial sustainability and efficiency of immunization financing expected to be completed by March 2020.">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The roadmap for financial sustainability is developed and agreed with the counterparts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Comprehensive in-service training and continuous professional education plans for vaccinators developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mid Level Managers (MLM) training for the distrcist supervisors">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">In 2021 Balochistan has conducted MLM in 33 districts (110 District officer) and KP in 8 districts (27participants).. Other provinces and areas could not conduct it due to competing priorities related to COVID and MR campaign preparations. Sindh has planned in December 2021 and others will conduct in Q1 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report on disease surveillance and impact evaluation activities. Final report on campaign coverage.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the first Gavi-supported Typhoid Gavi supported TCV introduction in Pakistan (approved Gavi application). Work in collaboration with the MOH, WHO and other partners (Aga Khan University) for planning and evaluation of the introduction in 2019 and 2020. CDC will be a key technical partner for AKU for evaluation of the TCV campaign over 3 - 4 years (CDC-HQ activities planned through TCA funds and will responsible for close coordination between the CDC in-country staff and other partners). TCV introduction in Pakistan is especially important to document given the occurence of the extensively drug resistant typhoid outbreak and impact of TCV on XRD outbreak control will be critical.">
      <location ref="PK"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">CDC Foundation was unable to re-program the funds and intends to return the unspent funds to Gavi. CDC is in discussion with WHO CO, EPI, and NIH to identify opportunities to strengthen typhoid surveillance and to conduct a deep dive into factors associated with being unvaccinated among eligible children with confirmed typhoid fever for 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the first Gavi-supported Typhoid Gavi supported TCV introduction in Pakistan (approved Gavi application). Work in collaboration with the MOH, WHO and other partners (Aga Khan University) for planning and evaluation of the introduction in 2019 and 2020. CDC will be a key technical partner for AKU for evaluation of the TCV campaign over 3 - 4 years (CDC-HQ activities planned through TCA funds and will responsible for close coordination between the CDC in-country staff and other partners). TCV introduction in Pakistan is especially important to document given the occurence of the extensively drug resistant typhoid outbreak and impact of TCV on XRD outbreak control will be critical.">
      <location ref="PK"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Previously, CDC had been in close touch with AKU and Gavi on the impact evaluation in Pakistan. CDC participated in AKU technical discussion calls on study design and provided feedback. CDC (HQ and country office) have had follow-up discussions with AKU and MOH on NIH-FETP involvement but these discussions have not gone any further. We are looking to reprogram the funds. One potential activity is to improve typhoid surveillance reporting in the weekly SitRep by the MOH. This information from the provinces with typhoid surveillance where FETP are active would help monitor TCV impact.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the first Gavi-supported Typhoid Gavi supported TCV introduction in Pakistan (approved Gavi application). Work in collaboration with the MOH, WHO and other partners (Aga Khan University) for planning and evaluation of the introduction in 2019 and 2020. CDC will be a key technical partner for AKU for evaluation of the TCV campaign over 3 - 4 years (CDC-HQ activities planned through TCA funds and will responsible for close coordination between the CDC in-country staff and other partners). TCV introduction in Pakistan is especially important to document given the occurence of the extensively drug resistant typhoid outbreak and impact of TCV on XRD outbreak control will be critical.">
      <location ref="PK"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Previously, CDC had been in close touch with AKU and Gavi on the impact evaluation in Pakistan. CDC participated in AKU technical discussion calls on study design and provided feedback. CDC (HQ and country office) have had follow-up discussions with AKU and MOH on NIH-FETP involvement but these discussions have not gone any further. We are looking to reprogram the funds. One potential activity is to improve typhoid surveillance reporting in the weekly SitRep by the MOH. This information from the provinces with typhoid surveillance where FETP are active would help monitor TCV impact.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Preliminary report of campaign activities, including coverage, and progress of evaluation activities.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the first Gavi-supported Typhoid Gavi supported TCV introduction in Pakistan (approved Gavi application). Work in collaboration with the MOH, WHO and other partners (Aga Khan University) for planning and evaluation of the introduction in 2019 and 2020. CDC will be a key technical partner for AKU for evaluation of the TCV campaign over 3 - 4 years (CDC-HQ activities planned through TCA funds and will responsible for close coordination between the CDC in-country staff and other partners). TCV introduction in Pakistan is especially important to document given the occurence of the extensively drug resistant typhoid outbreak and impact of TCV on XRD outbreak control will be critical.">
      <location ref="PK"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Previously, CDC had been in close touch with AKU and Gavi on the impact evaluation in Pakistan. CDC participated in AKU technical discussion calls on study design and provided feedback. CDC (HQ and country office) have had follow-up discussions with AKU and MOH on NIH-FETP involvement but these discussions have not gone any further. We are looking to reprogram the funds. One potential activity is to improve typhoid surveillance reporting in the weekly SitRep by the MOH. This information from the provinces with typhoid surveillance where FETP are active would help monitor TCV impact.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least one quarterly reviews meeting conducted in each province/areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Quarterly provincial/area EPI review meetings">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly comprehensive EPI review meetings were conducted in all Provinces and areas. Moreover EPI comprehensive programmatic review and data quality assessment was conducted in four provinces.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Quarterly provincial/area EPI review meetings">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly comprehensive EPI review meetings were conducted in all Provinces and areas. Moreover EPI comprehensive programmatic review and data quality assessment was conducted in four provinces.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documentation of demand generation activities for integrated services and new vaccine introductions in Pakistan.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Provide technical support in coordinating Human Centered Design (UCD) approaches to enhance community engagement interventions with PEI program, expanded partners and CSOs network to identify and refer missed/zero dose children for vaccination and create demand for immunization/integrated services in high risk, hard to reach areas and mega cities, including urban slums.

The staff member is also the focal point for COVID 19 vaccine roll out and monitoring appropriate planning and implementation, through monitoring cold chain and C4D specialists at subnational level

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH
&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Duplication: Milestone progress already reported above. This milestone needs to be removed as its a duplication.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Work in close coordination with EPI-PEI program and expanded parteners for integrated services around demand generation in high risk, hard to reach and targetted mega cities including urban slums.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Tailored ACSM interventions have been designed to address specific demand generation needs of communities in hard to reach, remote rural, urban slums, conflict prone and Polio Tier 1 districts. The interventions will utilize elements like influencer advocacy for change; human-centric community engagement for social and behavior change and risk management; social mobilization; and mass/social media engagement; technology for monitoring and reporting public sentiment; and public-private partnerships. The interventions have been laser focused in target union councils. EPI Rebranding exercise in 49 Centers in SHRUCs of Balochistan, KP and Sindh has been successfully completed. The status sheet for the first 50 centers can be accessed through the following link: https://docs.google.com/spreadsheets/d/1Cj9RhpODSMxd6whoHWjLmjQDljTEUTcpuxyYeezRBfE/edit#gid=678146720. 1403 centers will be rebranded during and rebranding work has been started from KP. Contracts with five CSOs for community engagement interventions are in place all provinces except KP including 10 mega cities. Action plans of all 5 CSOs on board have been approved and social profiling and baseline assessment will be completed by third week of June in Sindh, Balochistan, ICT/RWP and GB. New content was developed for digital media and field level community engagement for WIW activities and shared through EPI, PEI, MoH and UNICEF social media platforms and also through the mass media campaign during WIW. Federal EPI has recently approved mass media awareness activities for TV and Radio for quarter 3 and 4 for the MR campaign. Digital media campaigns were conducted with the exclusive hashtags of #MissionTyphoid (TCV Campaign 2021) and #VaccinesForPakistan (WIW 2021) in 2021 with a total reach of 30 million and 19 million respectively. The support also resulted in expanding Federal EPI?s official Facebook page?s reach to 59 million. vaccinators training on IPC, ToTs will begin from end-June 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Work in close coordination with EPI-PEI program and expanded parteners for integrated services around demand generation in high risk, hard to reach and targetted mega cities including urban slums.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Tailored ACSM interventions have been designed to address specific demand generation needs of communities in hard to reach, remote rural, urban slums, conflict prone and Polio Tier 1 districts. The interventions will utilize elements like influencer advocacy for change; human-centric community engagement for social and behavior change and risk management; social mobilization; and mass/social media engagement; technology for monitoring and reporting public sentiment; and public-private partnerships. The interventions have been laser focused in target union councils. EPI Rebranding exercise in 49 Centers in SHRUCs of Balochistan, KP and Sindh has been successfully completed. The status sheet for the first 50 centers can be accessed through the following link: https://docs.google.com/spreadsheets/d/1Cj9RhpODSMxd6whoHWjLmjQDljTEUTcpuxyYeezRBfE/edit#gid=678146720. 1403 centers will be rebranded during and rebranding work has been started from KP. Contracts with five CSOs for community engagement interventions are in place all provinces except KP including 10 mega cities. Action plans of all 5 CSOs on board have been approved and social profiling and baseline assessment will be completed by third week of June in Sindh, Balochistan, ICT/RWP and GB. New content was developed for digital media and field level community engagement for WIW activities and shared through EPI, PEI, MoH and UNICEF social media platforms and also through the mass media campaign during WIW. Federal EPI has recently approved mass media awareness activities for TV and Radio for quarter 3 and 4 for the MR campaign. Digital media campaigns were conducted with the exclusive hashtags of #MissionTyphoid (TCV Campaign 2021) and #VaccinesForPakistan (WIW 2021) in 2021 with a total reach of 30 million and 19 million respectively. The support also resulted in expanding Federal EPI?s official Facebook page?s reach to 59 million. vaccinators training on IPC, ToTs will begin from end-June 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&quot;Human Centered Design (UCD) approaches from the National Demand Roadmap Workshop used for planning evidence based community engagement interventions to reach children with essential immunization/health services through district specifc plans for the 46 priority districts under HSS-II.

Monthly Social Listening Analysis Reports around digital media to track, assess and address misinformation and
rumors on immunisation as well as COVID-19

&quot;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Provide technical support in coordinating Human Centered Design (UCD) approaches to enhance community engagement interventions with PEI program, expanded partners and CSOs network to identify and refer missed/zero dose children for vaccination and create demand for immunization/integrated services in high risk, hard to reach areas and mega cities, including urban slums.

The staff member is also the focal point for COVID 19 vaccine roll out and monitoring appropriate planning and implementation, through monitoring cold chain and C4D specialists at subnational level

Staff member will spend all required time to respond to FEPI and PEPI specific requests, support EPI program management (funding and results) in areas allocated to UNICEF and attend meetings as they are conveyed at national and subnational level (following UNICEF rules and regulations).
The relocation of the staff to Gov structure will have to be discussed between UNICEF management and MoH
&quot;">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Social profiling of target communities to understand the root causes was conducted, and identifies reasons for low coverage: perception of vaccines, experience at facility, views on vaccine preventable diseases. 
This data will guide the development of district specific communication action plans using human centered design approaches (in Dec 2021, after the MR campaign).
A total of 6 CSOs were engaged to strengthen community structures and ownership, establish health committees in selected locations aiming at empowering the communities to self monitor the vaccination status of their children refer children for vaccination (detect and refer), for resilience and sustainability.
Digitize the referral system between communities and service providers for better accountability 
Improve IPC skills of frontline workers to convince/reassure caregivers 
Provide access to accurate information in local languages through all available comms channels to reduce misinformation and vaccine hesitancy.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of immunization services in the delivery rooms and establishment of evening shift fpr EPI services in tertiary care hospitals in 10 urban districts in all provinces">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">134 EPI centers have started evening shift in Sindh, 11 in KP, Punjab 203(16 tertiary care , 36 DHQ and 151THQ), 
Birth dose in Labor room has been initiated in KP (11 hospitals) and Balochistan (15 Hospitals) and 31 in Sindh. Microplans, as well, identify these groups and describe reaching them during the EOA.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of immunization services in the delivery rooms and establishment of evening shift fpr EPI services in tertiary care hospitals in 10 urban districts in all provinces">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">134 EPI centers have started evening shift in Sindh, 11 in KP, Punjab 203(16 tertiary care , 36 DHQ and 151THQ), 
Birth dose in Labor room has been initiated in KP (11 hospitals) and Baluchistan (15 Hospitals) and 31 in Sindh. Microplans, as well, identify these groups and describe reaching them during the EOA.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development/update the cMYP, annual plans, at the national and provincial level. WHO will support in development of FPP through hiring consultants or facilitation process">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Nine cMYPs have been developed for all Provinces and National level. after consultations with the provinces and all relevant stakeholders. Annual Plans have been developed by the provinces. Full portfolio planning will start after the nationwide MR campaign.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development/update the cMYP, annual plans, at the national and provincial level. WHO will support in development of FPP through hiring consultants or facilitation process">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Nine cMYPs have been developed for all Provinces and National level.after consultations with the provinces and all relevant stakeholders.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the Full Portfolio Planning (FPP) in line with EPI strategic document (cMYP) at provincial and National level. consultants and facilitation and other tchnical and facilitation support will be provided.">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The cMYP has been developed. for all provinces and areas and for the National Level. However full portfolio planning has been delayed due to COVID and other priority activities mainly Measles Rubella campaign. the provincial coordination will start after the MR campaign</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap for improved integration of EPI with other PHC services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishment &amp; expansion of Integrated Service Delivery mechanism in SHRUCs and other distrcicts especailly urban">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Integrated service delivery has been started Super high-risk union councils (SHRUCS). Mobile team consists of Medical Officer, Health Technical/Dispenser, Vaccinator, Lady Health Worker/Community Health Worker/CBV, Local Social Mobilizer/Volunteer</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishment &amp; expansion of Integrated Service Delivery mechanism in SHRUCs and other distrcicts especailly urban">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Integrated service delivery has been started Super high-risk union councils (SHRUCS). Mobile team consists of Medical Officer, Health Technical/Dispenser, Vaccinator, Lady Health Worker/Community Health Worker/CBV, Local Social Mobilizer/Volunteer.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Refurbishment of selected EPI centers as per agreed scope of work throughout the country">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">1403 EPI centers are being refurbished through out the country 1340 have been completed and 73 are in the process and will be completed before 31 December 2021.
The province wise number of facilities completed. Punjab- 	292 
KPK	286
Sindh	331
Baluchistan 125
GB	57
Newly merged district (KP)	246</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Refurbishment of Health facilities for EPI &amp; Integrated services in the mega cities (Karachi, Peshawer, Quetta, Pishin and Killa Abdulla)">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">49 Health facilities (not just EPI centers) are refurbished in Sindh (Karachi), Baluchistan &amp; KPK (7 Baluchistan (Districts Kila Abdullah, Quetta, Pishin) , 18 KPK ( District Peshawar), 14 Sindh (Districts Karachi West and Malir))
Sindh Implements integrated outreach in SHRUCs during Polio campaigns. In June it is implemented in 37 selected sites, In Punjab 14 mobile teams are providing integrated services.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Refurbishment of Health facilities for EPI &amp; Integrated services in the mega cities (Karachi, Peshawer, Quetta, Pishin and Killa Abdulla)">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">49 planned Health facilities have been refurbished. in the Super high risk Union councils. in Karachi, Peshawar, Quetta , Pishin and Kila Abdullah.
I n addition 1403 facilities are being refurbished through out the country 1340 have been completed and 73 are in the process .</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Private Sector engagement in 10 Urban districts in four provinces">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Strategy for Private sector engagement is developed and provinces, with technical support of WHO have started negotiations with the private hospitals. In Punjab 25 new facilities are included in 2020 in already engaged 80 private facilities increasing the total to 105. Sindh is in negotiation with 68, Baluchistan has engaged 8, KP has identified and started negotiations with 76 private facilities out of which 10 private facilities have started EPI services.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Private Sector engagement in 10 Urban districts in four provinces">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Strategy for Private sector engagement is developed and provinces, with technical support of WHO have started negotiations with the private hospitals. In Punjab 25 new facilities are included in 2020 in already engaged 80 private facilities increasing the total to 105. Sindh is in negotiation with 68, Baluchistan has engaged 8, KP has identified and started negotiations with 76 private facilities out of which 10 private facilities have started EPI services.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development of quality microplans at the HF level following RED/REC strategy">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The Microplanning was done in all provinces and areas for routine vaccination service delivery. In addition Micro-plans for enhanced outreach and MR campaigns were also developed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical, logistics and financial support continues for existing IBD and Rotavirus sentinel sites</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="IBD and Rotavirus diseases surveillance">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">TTechnical support continued in 4 existing Rota and IBD sites, 2 in Punjab and 2 in Sindh, furthermore, an expansion in 2 more sites took place in Punjab and 2 in KP Increasing the total number of Rota sites to 8.There is a plan to include 1 more site in Baluchistan. Technical and logistic support continues in all new and existent sites.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="IBD and Rotavirus diseases surveillance">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">TTechnical support continued in 4 existing Rota and IBD sites, 2 in Punjab and 2 in Sindh, furthermore, an expansion in 2 more sites took place in Punjab and 2 in KP Increasing the total number of Rota sites to 8.There is a plan to include 1 more site in Baluchistan. Technical and logistic support continues in all new and existent sites.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">(1) Integrated 600 CCE with RTMDs.

(2) Documented cold chain equioment optamization plan (CCEOP) implementation and progress on establishment of CCE maintenance infrastructure</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the functionality and strenghtening of the Federal and Provincial immunization supply chain systems at all levels">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The integration of the 600 RTMDs into the vLMIS was delayed due to funding gaps for its procurement through the non-CCEOP from NISP-WB. This is resolved now and working with SD for supply of devices. We hope this activity would commence by 4th quarter of 2021.
The country has received its first batch of equipment of the CCEOP and discussion is ongoing between the vendor and the Provincial Project Monitoring Team (PMT) on Operational Deployment Plan (ODP) revision and prioritization. Not all required equipment has been received. Implementation of the CCEOP CCE would likely begin within the next month. Its after this that the planning for establishment of maintenance infrastructure would begin.
The major progress update for this activity is that the processes for implementation have started, the National Logistic Working Group (NLWG) have discussed and agreed on the provinces to prioritize installations.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the functionality and strenghtening of the Federal and Provincial immunization supply chain systems at all levels">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The integration of the 600 RTMDs into the vLMIS was delayed due to funding gaps for its procurement through the non-CCEOP from NISP-WB. This is resolved now and working with SD for supply of devices. We hope this activity would commence by 4th quarter of 2021.
The country has received its first batch of equipment of the CCEOP and discussion is ongoing between the vendor and the Provincial Project Monitoring Team (PMT) on Operational Deployment Plan (ODP) revision and prioritization. Not all required equipment has been received. Implementation of the CCEOP CCE would likely begin within the next month. Its after this that the planning for establishment of maintenance infrastructure would begin.
The major progress update for this activity is that the processes for implementation have started, the National Logistic Working Group (NLWG) have discussed and agreed on the provinces to prioritize installations.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documented progress on implementation of costed action plans to reach children with vaccines in targetted districts.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to the planning, development, implementation and monitoring of integrated immunization/health action plans in all targeted districts including urban settings including Quetta City and polio super highrisk union councils to ensure universal immunization coverage.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Action plan for Quetta including ACSM Plan, evening shifts, involvement of CSOs and implementation of 24/7 birth dose initiative is in progress. UNICEF continued supporting the roll out of 24/7 vaccination centres in maternity rooms of secondary and tertiary care hospitals from 4 sites in Quetta to 12 sites, both in public and private sector. In Quetta, 40,986 out of 42012 live births (98%) have been vaccinated.
ISD and referral is also being implemented in SHRUCs of Quetta block.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to the planning, development, implementation and monitoring of integrated immunization/health action plans in all targeted districts including urban settings including Quetta City and polio super highrisk union councils to ensure universal immunization coverage.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Action plan for Quetta including ACSM Plan, evening shifts, involvement of CSOs and implementation of 24/7 birth dose initiative is in progress. UNICEF continued supporting the roll out of 24/7 vaccination centres in maternity rooms of secondary and tertiary care hospitals from 4 sites in Quetta to 12 sites, both in public and private sector. In Quetta, 40,986 out of 42012 live births (98%) have been vaccinated.
ISD and referral is also being implemented in SHRUCs of Quetta block.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documented progress on equitable delivery of immunization services at all levels (Provincial,District,Facility and Community level).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to provincial, district, area and facility level in equity focused planning/ microplanning, implementation of plans and monitoring at all levels in repective provinces">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF Pakistan supported provincial and district health authorities to develop costed action plans for Lahore, Peshawar and Quetta under the leadership of provincial and district EPI. These city-specific action plans were informed by the urban slum profiling and immunization coverage survey results. Moreover, UNICEF Pakistan engaged international staff/consultants and in-country partners to support the government in the development of those plans. The same action plans have been reviewed and are being updated for 2021 in abovementioned targeted mega cities. The implementation of these action plan is delayed due to frequent lockdown due to third wave of covid- 19 pandemic.
Additionally, to increase the proportion of Penta 3 coverage to 80 per cent in the profiled slums of three union councils of Lahore, UNICEF contracted a third party to conduct a situation analysis and roll out integrated vaccination services including social mobilization in targeted union councils. Implementation will be followed by an evaluation and documentation of lessons learned. This activity will be completed by July 2021.
To increase routine immunization coverage (Penta 3, measles 1) and other health, nutrition, WASH interventions in urban cities, UNICEF Pakistan engaged provincial-level consultants and field monitors to provide technical support for planning and monitor implementation and take real time corrective actions. This support has helped to both build the EPI system and structure for integrated primary healthcare services in urban settings as well as help ensure their sustainability. All four provincial level consultants are onboard in Lahore, Quetta, Peshawar and Karachi to undertake this activity</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to provincial, district, area and facility level in equity focused planning/ microplanning, implementation of plans and monitoring at all levels in repective provinces">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF Pakistan supported provincial and district health authorities to develop costed action plans for Lahore, Peshawar and Quetta under the leadership of provincial and district EPI. These city-specific action plans were informed by the urban slum profiling and immunization coverage survey results. Moreover, UNICEF Pakistan engaged international staff/consultants and in-country partners to support the government in the development of those plans. The same action plans have been reviewed and are being updated for 2021 in abovementioned targeted mega cities. The implementation of these action plan is delayed due to frequent lockdown due to third wave of covid- 19 pandemic.
Additionally, to increase the proportion of Penta 3 coverage to 80 per cent in the profiled slums of three union councils of Lahore, UNICEF contracted a third party to conduct a situation analysis and roll out integrated vaccination services including social mobilization in targeted union councils. Implementation will be followed by an evaluation and documentation of lessons learned. This activity will be completed by July 2021.
To increase routine immunization coverage (Penta 3, measles 1) and other health, nutrition, WASH interventions in urban cities, UNICEF Pakistan engaged provincial-level consultants and field monitors to provide technical support for planning and monitor implementation and take real time corrective actions. This support has helped to both build the EPI system and structure for integrated primary healthcare services in urban settings as well as help ensure their sustainability. All four provincial level consultants are onboard in Lahore, Quetta, Peshawar and Karachi to undertake this activity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Progress reports are available to inform immuization programming</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support data collection,analysis and reporting on key imunization deliverables (financial and programatic) and knowledge management.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF has developed progress reports for all donors and have been submitted in time. The following Progress reports were developed and submitted in time .
1.	NISP MDTF progress report
2.	HSS 2 Additional funding ? Progress report
3.	Performance Based Funding (PBF) Grant Progress Report</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support data collection,analysis and reporting on key imunization deliverables (financial and programatic) and knowledge management.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF has developed progress reports for all donors and have been submitted in time. The following Progress reports were developed and submitted in time .
1.	NISP MDTF progress report
2.	HSS 2 Additional funding ? Progress report
3.	Performance Based Funding (PBF) Grant Progress Report</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Integrated health service delivery action plans implemented in identified low performing districts including targetted mega cities to increase routine immunization coverage.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance in the planning, development, implementation and monitoring of integrated Immunization/health strategies including EPI/PEI synergy. 
Strengthen coordination and partenerships with key stakeholders to reach missed and underserved children with immunization and basic PHC services through immunization system strengtheing.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF provided support to the national expanded programme on immunization (EPI) to review, update and thereby strengthen the existing EPI policy to enhance equity and coverage through systematic collection of gender disaggregated data, promotion of integrated service delivery, strengthening PPP, increasing the number of sessions for BCG and Measles per week in the high burden UCs and opening daily BCG and measles vials at secondary and tertiary level to reduce missed opportunities. These measures are aiming to contribute to mitigating the 
Negative impact of COVID 19 pandemic on the coverage. Additionally, UNICEF supported the federal EPI to develop and implement an immunization recovery plan during covid-19 pandemic. The implementation of the recovery plan has helped to maintain and sometimes improve the coverage of essential immunization at all levels. UNICEF further selected CSOs for community engagement in mega cities and HSS2 priority districts. UNICEF also supported inclusion of profiled 4500 slums in microplans of Karachi. Moreover, UNICEF supported prototype for urban slums is being rolled out in other targeted UCs of mega cities through same organization, CHIP, as expanded partner. The implementation targeted interventions in mega cities resulted in15-20 per cent increase in immunization coverage. UNICEF continued supporting the roll out of 24/7 vaccination centres in maternity rooms of secondary and tertiary care hospitals at 12 sites in Quetta,06 sites in Karachi and Hyderabad and 08 sites in KP, in both public and private sector. Through this initiative, about 40,986 of 42,012 (98%) new-born were vaccinated. UNICEF is also providing technical support for trainings of 3,000 newly recruited vaccinators in all provinces and areas and will be completed by Q4 of 2021. UNICEF is also supporting implementation of SHRUCs action plan and Health camps in Peshawar and Karachi to reach to zero dose, due and defaulters for essential immunization program.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance in the planning, development, implementation and monitoring of integrated Immunization/health strategies including EPI/PEI synergy. 
Strengthen coordination and partenerships with key stakeholders to reach missed and underserved children with immunization and basic PHC services through immunization system strengtheing.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF provided support to the national expanded programme on immunization (EPI) to review, update and thereby strengthen the existing EPI policy to enhance equity and coverage through systematic collection of gender disaggregated data, promotion of integrated service delivery, strengthening PPP, increasing the number of sessions for BCG and Measles per week in the high burden UCs and opening daily BCG and measles vials at secondary and tertiary level to reduce missed opportunities. These measures are aiming to contribute to mitigating the 
Negative impact of COVID 19 pandemic on the coverage. Additionally, UNICEF supported the federal EPI to develop and implement an immunization recovery plan during covid-19 pandemic. The implementation of the recovery plan has helped to maintain and sometimes improve the coverage of essential immunization at all levels. UNICEF further selected CSOs for community engagement in mega cities and HSS2 priority districts. UNICEF also supported inclusion of profiled 4500 slums in microplans of Karachi. Moreover, UNICEF supported prototype for urban slums is being rolled out in other targeted UCs of mega cities through same organization, CHIP, as expanded partner. The implementation targeted interventions in mega cities resulted in15-20 per cent increase in immunization coverage. UNICEF continued supporting the roll out of 24/7 vaccination centres in maternity rooms of secondary and tertiary care hospitals at 12 sites in Quetta,06 sites in Karachi and Hyderabad and 08 sites in KP, in both public and private sector. Through this initiative, about 40,986 of 42,012 (98%) new-born were vaccinated. UNICEF is also providing technical support for trainings of 3,000 newly recruited vaccinators in all provinces and areas and will be completed by Q4 of 2021. UNICEF is also supporting implementation of SHRUCs action plan and Health camps in Peshawar and Karachi to reach to zero dose, due and defaulters for essential immunization program.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documented knowledge products,Case studies, lesson learned, best practices and human interest stories.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to the planning, development, implementation and monitoring of integrated immunization/health strategies in targetted hgh risk distircts including mega cities to ensure universal immunization coverage through immunization system strengthening.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF supported provincial and Federal EPI in documentation of lesson learned from TCV campaign in Sindh which has been used to inform implementation of TCV Campaign in Punjab and Islamabad. The report is attached for reference. Two publications have also been developed and are in process of publication.UNICEF also supported EPI Program in documentation of urban slums profiling and immunization coverage survey results in Pakistan. Final report is attached for reference. Three (03) scientific publications have also been developed and being published for knowledge management.
UNICEF supported development of ?Strengthening Services Beyond Immunization Approach?, which is being implemented in polio super high-risk union councils in Balochistan, Khyber Pakhtunkhwa (KP) and Sindh to support polio eradication while enhancing the overall socioeconomic conditions and physical resilience of residents through the provision of basic social services. Immunization services integrated with basic maternal, new-born and child healthcare (MNCH), nutrition, WASH, and birth registration are being implemented to increase the access to and uptake of essential vaccines by target population. During the pilot phase, implemented in 2020/21 across seven super high-risk union councils (SHRUC) in KP, Sindh and Balochistan, a total of 108,187 children received basic primary healthcare services including basic curative services, routine immunization and nutrition services. Additionally, about 250,000 persons (62,500 men, 65,000 women, 61381 boys and 61,119 girls) were reached with WASH services in these SHRUCs.Integrated referral slip initiative has also been launched in seven SHRUCs and is being rolled out in other UCs. UNICEF also supported FEPI in development of Framework for independent monitoring which has been endorsed by all provinces and areas. UNICEF also supported national EPI review meeting in June 2021. The final report with clear action points will be circulated soon.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance to the planning, development, implementation and monitoring of integrated immunization/health strategies in targetted hgh risk distircts including mega cities to ensure universal immunization coverage through immunization system strengthening.">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF supported provincial and Federal EPI in documentation of lesson learned from TCV campaign in Sindh which has been used to inform implementation of TCV Campaign in Punjab and Islamabad. The report is attached for reference. Two publications have also been developed and are in process of publication.UNICEF also supported EPI Program in documentation of urban slums profiling and immunization coverage survey results in Pakistan. Final report is attached for reference. Three (03) scientific publications have also been developed and being published for knowledge management.
UNICEF supported development of ?Strengthening Services Beyond Immunization Approach?, which is being implemented in polio super high-risk union councils in Balochistan, Khyber Pakhtunkhwa (KP) and Sindh to support polio eradication while enhancing the overall socioeconomic conditions and physical resilience of residents through the provision of basic social services. Immunization services integrated with basic maternal, new-born and child healthcare (MNCH), nutrition, WASH, and birth registration are being implemented to increase the access to and uptake of essential vaccines by target population. During the pilot phase, implemented in 2020/21 across seven super high-risk union councils (SHRUC) in KP, Sindh and Balochistan, a total of 108,187 children received basic primary healthcare services including basic curative services, routine immunization and nutrition services. Additionally, about 250,000 persons (62,500 men, 65,000 women, 61381 boys and 61,119 girls) were reached with WASH services in these SHRUCs.Integrated referral slip initiative has also been launched in seven SHRUCs and is being rolled out in other UCs. UNICEF also supported FEPI in development of Framework for independent monitoring which has been endorsed by all provinces and areas. UNICEF also supported national EPI review meeting in June 2021. The final report with clear action points will be circulated soon.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Community based surveillance system implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Community Based Surveillance (CBS) establishment and strengthening">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">A total of 1583 LHWs and LHS were trained on Community based surveillance reporting. 
1320 Peshawar/KP 
191 in Sindh (SHRUCH 8 UCs) 
72 in Baluchistan (SHRUC) 
176 received TOT training on CBS</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Community Based Surveillance (CBS) establishment and strengthening">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">A total of 1583 LHWs and LHS were trained on Community based surveillance reporting.
1320 Peshawar/KP
191 in Sindh (SHRUCH 8 UCs)
72 in Baluchistan (SHRUC)
176 received TOT training on CBS</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data dashboard implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Expand the EPI MIS to Punjab and Sind">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">All Provinces are reporting online .KP, Baluchistan, AJK, and GB through MIS. Sindh is reporting surveillance data through vLMIS and Punjab is currently using VPD Surveillance and response system managed Punjab information and Technology board.. To have one uniform reporting platform WHO has contracted an agency for MIS introduction in Sindh and Punjab. All districts will report via MIS by Nov 2021.
Components of MIS:
?	Admin data reporting
?	Expansion of Web based surveillance to Sindh and Punjab
?	Real time collection of VPDs/AEFI data through mobile app
Progress:
?	Firm contracted by WHO
?	Various meetings and requirements analysis conducted
?	Software for all the modules is developed
?	Mobile app for VPD surveillance is developed
?	Desk testing and bug fixing is done
?	Field Testing will be done in December 2021 after nation wide mega MR campaign (15-27 Nov 2021)
?	Training of District Data officers to be done in Dec 2021
?	Training of VPD focal points will be done in Dec 2021
?	Deployment of Software in the field will be done in Dec 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Expansion of the web based Surveillance reporting to Punjab and Sindh">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">All Provinces are reporting online .KP, Baluchistan, AJK, and GB through MIS. Sindh is reporting surveillance data through vLMIS and Punjab is currently using VPD Surveillance and response system managed Punjab information and Technology board.. To have one uniform reporting platform WHO has contracted an agency for MIS introduction in Sindh and Punjab. All districts will report via MIS by Nov 2021.
Components of MIS:
?	Admin data reporting
?	Expansion of Web based surveillance to Sindh and Punjab
?	Real time collection of VPDs/AEFI data through mobile app
Progress:
?	M/S Micromerger contracted by WHO
?	Various meetings and requirements analysis conducted
?	Software for all the modules is developed
?	Mobile app for VPD surveillance is developed
?	Desk testing and bug fixing is done
?	Field Testing will be done in December 2021 after nation wide mega MR campaign (15-27 Nov 2021)
?	Training of District Data guys to be done in Dec 2021
?	Training of VPD focal points will be done in Dec 2021
?	Deployment of Software in the field will be done in Dec 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Quarterly provincial/area EPI review meetings">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">All quarterly provincial level meetings in all provinces and areas were conducted in 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Quarterly provincial/area EPI review meetings">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly EPI reviews are conducted in all provinces and areas. WHO is supporting regular monthly (district) and quarterly review (provincial) meetings. MIS database , EIR in Sindh through Mobile App (Zindagi Mahfooz; ZM) and in KP SERV (Android based application to track and register every vaccinated child.
Data received from all provinces and areas is reviewed and analyzed at the Provincial as well as National level triangulated with disease surveillance data. (latest report attached for Data and VPD surveillance)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data Improvement Plan (DIP) developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="DQA conducted and DQ IP developed in atleaast 50% of districts">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Data quality assessment was conducted by WHO along with other partners in KP , Punjab, Sindh and Baluchistan. in 2021. Next round will be conducted in 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">e-Surveillance platform implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Real time collection of VPDs/AEFI data through mobile app">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Mobile app for VPD surveillance is developed.?	Training of VPD focal points will be done in Dec 2021. Procurement of gadgets was delayed due to supplier-related issues. WHO is in the process of hiring another vendor. gadgets are expected before the training .</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and approaches developed to improve and sustain quality and safety of immunisation services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Real time collection of VPDs/AEFI data through mobile app">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Procurement of gadgets (tablets) is done, Review of all online reporting lists has been conducted. Testing of pilot software is ongoing. Training are planned in August and reporting is expected from November.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Development of national VPDs/AEFI guideline and update the capacity building package of VPDs">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Revised guideline developed (attached)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">New specific VPD surveillance system implemented or integrated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishing and sustaining the Typhoid surveillance sites in all provinces and areas">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">From April 2020 up to April 2021, a total of 14 Typhoid sentinel sites were established, 5 in Punjab, 5 in Sindh, 3 in KP and 1 in Baluchistan. Expansion of number of sites is in process, and additional site in Baluchistan. and one in Islamabad will start functioning from in July 2021. The total of 14,376 suspected typhoid cases were reported, of which 98% (14,146) were tested, 12% (1,679) were lab confirmed typhoid, of which 65% (1,088) were XDR typhoid. (Typhoid Sentinel site report is attached) it?s integrated with private and Academia</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="IBD, Rotavirus and CRS sentinel sites maintained and expanded to include all provinces">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Technical support continued in 4 existing Rota and IBD sites, 2 in Punjab and 2 in Sindh, furthermore, an expansion in 2 more sites took place in Punjab and 2 in KP Increasing the total number of Rota sites to 8.There is a plan to include 1 more site in Baluchistan. Technical and logistic support continues in all new and existent sites.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishing and sustaining the Typhoid surveillance sites in all provinces and areas">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Up to Oct 2021, A total of 16 Typhoid sentinel sites are supported, (5 In Punjab, 5 In Sindh, 3 in KP, 2 in Baluchistan), of which, 1 site was included in the Typhoid surveillance network in July 2021 in Baluchistan. Through sentinel sites surveillance, a total of 31,671 suspected typhoid cases were reported, of which 99% (31,441) were tested. 10% (3,049) were Typhoid lab-confirmed, of which 66% (2,008) were XDR typhoid</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">VPD surveillance assessment performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the national Measles/Rubella Lab (NIH) and expand the MR lab network">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">For VPDs/AEFI surveillance strengthening WHO has developed guidelines, supported field monitoring, investigations, data collection, analysis, and interpretation. Weekly bulletins are supported and monthly reports are generated by provinces and at National level. (latest report attached) .
National Lab for VPD Surveillance (NIH) is being supported with HR and logistics.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="IBD, Rotavirus and CRS sentinel sites maintained and expanded to include all provinces">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Technical, lab, and logistic support are sustained in 8 Rota sites (4 Punjab, 2 Sindh, and 2 in KP), in addition to expansion to one site in Baluchistan, where the training of lab and data entry staff was conducted in the last week of October, reporting is expected to start from November. 
Support to 5 CRS sites are also sustained, regular monthly reports are distributed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the national Measles/Rubella Lab (NIH) and expand the MR lab network">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">VPDs guideline was edited, printed, and distributed to all provinces. A total of 17,894 suspected measles/rubella cases were reported, of which 16,096 were lab tested. 70 measles outbreaks were investigated and outbreak responses were conducted. Weekly bulletins are supported and monthly reports are generated by provinces and at the National level. (latest report attached). 
National Lab for VPDs surveillance at NIH is being supported with HR, logistics, and capacity building</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Remaining 50% of districts will be reporting on web based</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Online web based Surveillance reporting established throughout the country">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">All Provinces are reporting online .KP, Baluchistan, AJK, and GB through MIS. Sindh is reporting surveillance data through vLMIS and Punjab is currently using VPD Surveillance and response system managed Punjab information and Technology board.. To have one uniform reporting platform WHO has contracted an agency for MIS introduction in Sindh and Punjab .All districts will report via MIS by Nov 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Online web based Surveillance reporting established throughout the country">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">All Provinces are reporting online .KP, Baluchistan, AJK, and GB through MIS. Sindh is reporting surveillance data through vLMIS and Punjab is currently using VPD Surveillance and response system managed Punjab information and Technology board.. To have one uniform reporting platform WHO has contracted an agency for MIS introduction in Sindh and Punjab .All districts will report via MIS by Nov 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual Workplans developed for all Provinces and areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Development of Annual Workplans">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Annual workplans are developed by all Provinces and areas</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Development of Annual Workplans">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Annual workplans are developed by all Provinces and areas</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">DQA conducted in one province/area</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="DQA conducted and DQ IP developed">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Data quality assessment was conducted by WHO along with other partners in KP , Punjab, Sindh and Baluchistan. The DQA reports are attached ..</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="DQA conducted and DQ IP developed">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Data quality assessment was conducted by WHO along with other partners in KP , Punjab, Sindh and Baluchistan. The DQA reports are attached ..</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">MLM training conducted for 25% districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mid level managers training conducted">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">MLM training has been conducted in 36 districts in Punjab (23%) in 2020. In 2021 Balochistan has conducted MLM in 33 districts (110 District officer) and KP in 8 districts (27participants). Total of 38 district management teams are trained in 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Mid level managers training conducted">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">MLM training has been conducted in 36 districts in Punjab (23%) in 2020. In 2021 Balochistan has conducted MLM in 33 districts (110 District officer) and KP in 8 districts (27participants). Total of 38 district management teams are trained in 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training workshops conducted for remaining 25% of districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building for development of district and UC level microplan following RED/REC strategy">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Microplanning workshops have been conducted in all provinces and areas. all microplans are updated on quarterly basis.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building for development of district and UC level microplan following RED/REC strategy">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Microplanning workshops have been conducted in all provinces and areas. all microplans are updated on quarterly basis.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical, logistics and financial support continues for existing CRS sites</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CRS surveillance">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Technical support continued in 5 existing CRS sites, 3 in Punjab and 2 in Sindh. Refresher training to all CRS sentinel sites was conducted</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="CRS surveillance">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Technical support continued in 5 existing CRS sites, 3 in Punjab and 2 in Sindh. Refresher training to all CRS sentinel sites was conducted</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">One sub national mealses lab will be functional</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Laboratory support for antional MR Lab (NIH) and expand the MR lab network">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The process of expansion of Measles laboratory at provincial level was initiated. at Khyber Medical university Peshawar, Public health Lab in Baluchistan.
assessments and training of lab staff were completed. However due to certain management issues, the labs are not functional. Discussions for the upgrading Institute of Public Health Punjab are going on.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Laboratory support for antional MR Lab (NIH) and expand the MR lab network">
      <location ref="PK"></location>
     </target>
     <actual value="On Track">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">The process of expansion of Measles laboratory at provincial level was initiated. at Khyber Medical university Peshawar, Public health Lab in Baluchistan.
assessments and training of lab staff were completed. However due to certain management issues, the labs are not functional. Discussions for the upgrading Institute of Public Health Punjab are going on.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">VPD and AEFI trainibgconducted for 25% districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building on revised VPD andAEFI guidelines">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">VPD and AEFI training has been conducted in 115 (75%) districts.in 2020. GB and AJK will complete training in Q2 of 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Capacity building on revised VPD andAEFI guidelines">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">VPD and AEFI training has been conducted in 115 (75%) districts.in 2020. GB and AJK will complete training in Q2 of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least one comprehensive EPI review meeting to be condcuted in one provicne/area</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Comprehensive EPI review conducted">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly comprehensive EPI review meetings were conducted in all Provinces and areas. Moreover EPI comprehensive programmatic review and data quality assessment was conducted in four provinces.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Comprehensive EPI review conducted">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">Quarterly comprehensive EPI review meetings were conducted in all Provinces and areas. Moreover EPI comprehensive programmatic review and data quality assessment was conducted in four provinces.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Comprehensive EPI review conducted">
      <location ref="PK"></location>
     </target>
     <actual value="Completed">
      <location ref="PK"></location>
      <comment>
       <narrative xml:lang="EN">quarterly comprehensive EPI review meetings were conducted in all Provinces and areas. Moreover EPI comprehensive programmatic review and data quality assessment was conducted in four provinces.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed
2. Data quality app installed
3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="PK"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PK"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed 2. Data quality app installed 3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="PK"></location>
     </target>
     <actual>
      <location ref="PK"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="PK"></location>
     </target>
     <actual>
      <location ref="PK"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
